IDEAYA Biosciences Cash from Financing (Quarterly) Trends

IDEAYA Biosciences Inc (IDYA)

26.79 +0.19 (+0.71%) USD | NASDAQ | Nov 22, 16:00

26.77 -0.02 (-0.07%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	286.50M
June 30, 2024	39.18M
March 31, 2024	349.11M
December 31, 2023	140.89M
September 30, 2023	27.83M
June 30, 2023	191.06M
March 31, 2023	2.926M
December 31, 2022	0.324M
September 30, 2022	95.70M
June 30, 2022	0.491M
March 31, 2022	0.653M
December 31, 2021	0.688M
September 30, 2021	86.78M
June 30, 2021	15.99M

Date	Value
March 31, 2021	42.00M
December 31, 2020	6.949M
September 30, 2020	27.07M
June 30, 2020	94.70M
March 31, 2020	0.034M
December 31, 2019	0.038M
September 30, 2019	-0.276M
June 30, 2019	51.67M
March 31, 2019	-0.826M
December 31, 2018	-0.077M
September 30, 2018	0.041M
June 30, 2018	-0.006M
March 31, 2018	105.42M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

0.034M

Minimum

Mar 2020

349.11M

Maximum

Mar 2024

70.45M

Average

27.45M

Median

Cash from Financing (Quarterly) Benchmarks

Gilead Sciences Inc	-1.379B
Vertex Pharmaceuticals Inc	-387.50M
Black Diamond Therapeutics Inc	-0.252M
NovaBay Pharmaceuticals Inc	2.089M
Palatin Technologies Inc	-0.127M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-49.23M
Cash from Investing (Quarterly)	-20.04M
Free Cash Flow	-153.27M
Free Cash Flow Per Share (Quarterly)	-0.5765
Free Cash Flow Yield	-7.51%